Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Lilly Announces Leadership Transition in Human Resources and New Chief Commercial Officer for Loxo@Lilly
Eli Lilly and Company (NYSE: LLY) today announced the upcoming retirement of one executive committee member, […]
Full-Life Technologies Deepens Radioisotope Technology Expertise with Key Leadership Appointments and the Establishment of a Radioisotope Technology Advisory Board
Full-Life Technologies Co., Ltd. (“Full-Life”) today announced two key appointments to its Radioisotope Technology leadership team […]
Transcenta Announces the Appointment of Dr. Caroline Germa as Executive Vice President, Global Medicine Development and Chief Medical Officer
Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in […]
Laronde Appoints John Mendlein as Chief Executive Officer
Laronde, the company pioneering Endless RNA™ (eRNA) – a novel, engineered form of RNA that […]
Immunologix Laboratories Appoints Dr. Corinna Fiorotti As Chief Commercial Officer (CCO)
Immunologix Laboratories announced today that Dr. Corinna Fiorotti has been appointed Chief Commercial Officer. An experienced science and business […]
Verana Health Fuels for Growth with the Appointment of Chris Reiling as Chief Revenue Officer and Lawrence Whittle as Chief Commercial Officer
Verana Health®—a digital health company elevating quality in real-world data—today announced the appointments of Chris Reiling as […]
Gracell Biotechnologies Appoints Accomplished Clinical Leader Dr. Wendy Li as Chief Medical Officer
Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated […]
Vico Therapeutics Appoints Micah Mackison as Chief Executive Officer
Vico Therapeutics B.V., a neurology-focused genetic medicine company, today announced the appointment of Micah Mackison as Chief […]
PacBio Announces Appointment of Genomics Industry Veteran Jeff Eidel as Chief Commercial Officer
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Jeff […]
Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer Detection
Acuamark Diagnostics (“AcuamarkDx”), an early cancer detection company, today announced the closing of an $11.3 million Series […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more